Raymond M. Dunn, MD
Raymond M. Dunn, MD, is the Chief of the Division of Plastic Surgery at the University of Massachusetts Medical School and UMass Memorial Health Care in Worcester, Mass. Dr. Dunn is Professor of Surgery and Cell Biology at the University of Massachusetts Medical School and Adjunct Professor of Biomedical Engineering at Worcester Polytechnic Institute. Dr. Dunn completed full training in General Surgery at the University of Massachusetts Medical School, followed by Plastic Surgery training at the Eastern Virginia Graduate School of Medicine, receiving board certifications in General Surgery, Plastic Surgery and Hand Surgery.
In addition to multiple grants and numerous publications, Dr. Dunn holds a number of medical device patents issued and pending. He has an active clinical practice in Plastic, Hand and cosmetic surgery and strong involvement in the education and training of undergraduate and graduate students in Biomedical engineering, and in General and Plastic surgery training.
Keith H. S. Campbell, Ph.D.
Keith H.S. Campbell, Ph.D., is a cell biologist/embryologist with 30 years scientific experience 25 of which have been in the field of cell growth and differentiation. He obtained a BSc (Hon’s) in Microbiology from Queen Elizabeth College London (1978) and a D.Phil from the University of Sussex (1986).Following two postdoctoral positions he joined the Roslin Institute in 1991 to study the production of mammalian embryos by nuclear transfer. This research led to the production of the first mammals to be ‘cloned’ from cultured differentiated cells (Nature 380:64-66, 1996), the first mammal to be ‘cloned’ from an adult derived somatic cell ‘DOLLY’ (Nature 385: 810-813, 1997) and in collaboration with PPL Therapeutics, the first transgenic mammal to be produced by nuclear transfer (Science 278:2130-2133, 1997). In July 1997 he became Head of Embryology at PPL-Therapeutics. Whilst at PPL the first gene targeted lambs (Cupid and Diana) were born (Nature 405: 1066-1069 (2000) and also the world’s first piglets cloned from somatic cells (Nature 407:505-509 (2000). In November 1999, Keith became Professor of Animal Development at the University of Nottingham where he continues research into the basic mechanisms underlying development and differentiation. Keith serves on a number of editorial boards including Cloning and Stem Cells and Reproduction and is a member of several scientific advisory boards including both academia (Gene Center , Munich. Genome Center, Brazil) and industry (Advanced cell Technologies, USA. Cellcentric, UK).
Stephen Doxsey, Ph.D.
Stephen Doxsey, Ph.D., prior to obtaining his Ph.D. degree, Stephen worked with Drs. Elio Raviola and Torsten Wiesel (Nobel Prize Laureate) at Harvard Medical School studying myopia. He then traveled to East Africa (Kenya) to work with Don Fawcett on cattle diseases (trypanosomiasis, theileriosis, 1980-1982). He received his Ph.D. in Cell Biology from Yale University in 1987 under the supervision of Ari Helenius and Ira Mellman. He subsequently did postdoctoral training with Marc Kirschner at UCSF where he was awarded Damon Runyon and Anna Fuller Fellowships to study centrosome function. In 1993 he was appointed as Assistant Professor in Molecular Medicine at the University of Massachusetts Medical School, Worcester. In 2004 he was promoted to Professor. His laboratory is focused on understanding how centrosomes organize microtubule arrays such as the mitotic spindle and how they regulate other cellular functions such as cytokinesis and cell cycle progression. He also studies the role of centrosomes in cancer and in autoantibody development in human autoimmune diseases. He recently received the prestigious W.M. Keck Foundation Senior Scholar Award for “Pioneering work on mitosis”. He received Distinguished Faculty Awards for co-establishing a Graduate Recruitment Program at UMass and for organizing UMass laboratories for four Worcester Area High Schools. He is an Associate Editor for Mol Biol Cell, Traffic and J Cell Physiol and a member of review panels for Breast Cancer and Prostate Cancer for the Department of Defense and for the National Institutes of Health. He recently licensed two patents to Cytyc Corporation, which manufactures PAP smears to detect cancer and has sponsored research agreements with AstraZeneca, Cytyc and Novartis.
Marsha W. Rolle, Ph.D.
Marsha W. Rolle, Ph.D., joined the faculty at Worcester Polytechnic Institute as an Assistant Professor in the Department of Biomedical Engineering in July 2007. She earned her Ph.D. in Bioengineering at the University of Washington in Seattle, Washington, where she developed a system to control skeletal muscle cell proliferation for myocardial infarct repair as a graduate student in Chuck Murry’s laboratory. As a postdoctoral fellow in Thomas Wight’s laboratory at the Benaroya Research Institute in Seattle, she was awarded a Ruth L. Kirschstein National Research Service Award from the National Heart, Lung and Blood Institute to develop regulatable systems to control elastin synthesis and assembly in tissue engineered blood vessels. Current research in the Rolle lab is focused on developing genetic and cellular engineering approaches to control extracellular matrix synthesis in tissue engineered constructs, and to quantify the effects of matrix manipulation on the mechanical and physiological properties of engineered tissues.
Charles (Chuck) E. Murry, M.D., Ph.D.
Charles (Chuck) E. Murry, MD, Ph.D., is Professor of Pathology at the University of Washington in Seattle, Director of the Center for Cardiovascular Biology and Co-Director of the newly formed Institute for Stem Cell and Regenerative Medicine at the South Lake Union research complex. He obtained his Ph.D. and M.D. from Duke University, and did a fellowship in vascular biology at the University of Washington under Stephen M. Schwartz, M.D., Ph.D. His awards include the Presidential Early Career Award in Science and Engineering in 2000. The Murry Lab’s research focuses on myocardial infarctions and the heart’s lack of intrinsic regenerative ability. Work centers on the biology of myocardial infarction, both in defining the molecular mechanisms that underlie the heart's normal wound healing processes and in developing molecular and cell-based approaches to improve infarct repair. They are a multidisciplinary group, doing basic work in molecular biology and regulation of gene expression, cell biology, tissue engineering, mouse models of disease, and analyses of human tissues.
Stephen Francis Badylak, D.V.M., M.D., Ph.D.
Stephen Francis Badylak, D.V.M., M.D., Ph.D., is a Research Professor in the Department of Surgery and director of the Center for Preclinical Testing at the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. In 1976, he received his D.V.M. from Purdue University and he completed his M.S. in Clinical Pathology from Purdue University in 1978. Dr. Badylak also holds a Ph.D. in Anatomic Pathology from Purdue University (1981) and graduated with highest honors with a M.D. from Indiana University Medical School in 1985.
Prior to his post graduate training, Dr. Badylak practiced veterinary medicine at a mixed animal practice in Glenwood, Illinois and in Hobart, Indiana. Dr. Badylak began his academic career at Purdue University in 1983 as an Assistant Research Scholar at the Hillenbrand Biomedical Engineering Center.
During his tenure at Purdue University, Dr. Badylak held a variety of positions including Postdoctoral Research Associate (1985) and Associate Research Scholar (1988) and he eventually served as the Director of the Hillenbrand Biomedical Engineering Center from 1995-1998. Dr. Badylak held a dual appointment as an Associate Professor within the Department of Veterinary Physiology and Pharmacology and also practiced medicine as the Head Team Physician for the Athletic Department for 16 years (1985-2001). Prior to joining the faculty of the University of Pittsburgh, Dr. Badylak served as Senior Research Scientist within the Department of Biomedical Engineering at Purdue University and Adjunct Associate Professor of Pathology and Laboratory Medicine at the Indiana University School of Medicine.
Dr. Badylak holds over 40 US patents and 200 patents worldwide and has authored more than 160 scientific publications and 12 book chapters. He has served as the Chair of the Purdue University Tissue Engineering Advisory Board and as chair of several Study Sections for the National Institutes of Health (NIH), including the bioengineering, Technology, and Surgical Sciences Study Section. Dr. Badylak has either chaired or been a member of the Scientific Advisory Board to several major medical device companies.
Dr. Badylak is a Fellow of the American Institute for Medical and Biological Engineering. He is a charter member and the North American delegate to the Tissue Engineering Regenerative Medicine International Society (TERMIS). Dr. Badylak also holds an Adjunct Professorship at Wake Forest University School of Medicine and at the Wake Forest Institute for Regenerative Medicine and is a member of the Society for Biomaterials. Dr. Badylak is the Associate Editor for Tissue Engineering for the journal Cells, Tissues, Organs. For his contributions to the fields of Regenerative Medicine and Biomaterials, he has been the recipient of awards such as the Sigma Xi Scientific Society 2002 Research Award, the Clemson Award – (Society for Biomaterials) in 2005, Pittsburgh Business Times Hero in Healthcare finalist – 2005, and the Carnegie Science Center Award for Excellence – in 2005.
Ken Muneoka, Ph.D.
Ken Muneoka, Ph.D., is Professor in the Department of Cell and Molecular Biology at Tulane University. He received his PhD degree from the University of California Irvine and joined the faculty at Tulane University as Assistant Professor in 1986. He currently holds the rank of Professor and served as Chair of the Department of Cell and Molecular Biology from 1993 to 2005. Dr. Muneoka currently holds the John L. and Mary Wright Ebaugh Chair in Tulane’s School of Science and Engineering. Dr. Muneoka has served as Editor for the Division of Developmental Biology of the Journal of Experimental Zoology, as Associate Editor for the journal Developmental Biology and is currently on the editorial board of BMC Developmental Biology. He has served as a member of United States Army Science Board, the Advisory Board of the United States Veterans Administration Office of Regeneration Research Programs, as well as on numerous NIH study sections. Dr. Muneoka is an elected fellow of the American Association for the Advancement of Science. Dr. Muneoka has carried out pioneering research in limb development and regeneration.
Abstracts/Presentations | Speaker BiosMaintained by firstname.lastname@example.org
Last modified: September 17, 2007 13:34:32 Maintained by email@example.com
Last modified: September 17, 2007 13:34:32